ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections

Journal of Infectious Diseases

Volumn 185, Issue 2, 2002, Pages 214-219

  Jelacic, Srdjan ^a   Wobbe, Cheryl L ^b   Boster, Daniel R ^a   Ciol, Marcia A ^b   Watkins, Sandra L ^a   Tarr, Phillip I ^a,b   Stapleton, Ann E ^b  

^a Landstuhl Regional Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BLOOD GROUP ANTIGEN; ERYTHROCYTE ANTIGEN; SHIGA TOXIN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP P SYSTEM; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; FEMALE; GENOTYPE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ANTIGENS, NUCLEAR; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; GENOTYPE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; LOGISTIC MODELS; MALE; NUCLEAR PROTEINS; PROSPECTIVE STUDIES; RISK FACTORS; SHIGA TOXIN;

EID: 0037080046     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/338480     Document Type: Article

References (33)

1. Escherichia coli Shiga toxin
2. Escherichia coli O157:H7 and the hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
3. Pathogenesis of shigella diarrhea XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide
4. Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro
5. The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome
6. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns
7. Erythrocyte P1 group antigen expression in VTEC-associated hemolytic uremic syndrome
8. The P1 blood group and the severity of diarrhea-associated hemolytic uremic syndrome
9. P1 blood group antigen expression and epidemic hemolytic uremic syndrome
10. Haemolytic uraemic syndrome: Prognostic factors
11. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences
12. The natural anti-Gal antibody
13. Biophysical characteristics of anti-Gal(α) 1-3Gal IgM binding to cell surfaces: Implications for xenotransplantation
14. Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection
15. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies
16. Specific interaction of Escherichia coli O157: H7-derived Shiga-like toxin II with human renal endothelial cells
17. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice
18. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections
19. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans
20. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2
21. The risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
22. Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children
23. Iha: A novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure
24. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages
25. Escherichia coli O157:H7 and O157: H(-) strains that do not produce Shiga toxin: Phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome
26. Nontoxigenic sorbitol-fermenting Escherichia coli O157:H-associated with a family outbreak of diarrhoea
27. Risk factors for recurrent urinary tract infection in young women
28. Escherichia coli O157:H7-associated hemolytic uremic syndrome plasma has normal von Willebrand factor-cleaving proteaseinase activity but increased von Willebrand factor proteolysis
29. Hemolytic uremic syndrome epidemiology: A population-based study in King County, Washington, 1971 to 1980
30. A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982
31. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea